Status:

COMPLETED

4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting

Lead Sponsor:

Vanderbilt University Medical Center

Collaborating Sponsors:

American Thoracic Society

Conditions:

Copd

Emphysema

Eligibility:

All Genders

18+ years

Brief Summary

This study will investigate the utility of 4D Medical's X-ray Velocimetry (XV) imaging analysis software for the detection of hyperinflation, and compare endobronchial valve placement outcomes with pr...

Eligibility Criteria

Inclusion

  • Inclusion:
  • CT chest and PFTs within the last two years
  • Age over 18
  • COPD with emphysema
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3 - 4 classification OR modified Medical Research Council (mMRC) score of 2 or greater.
  • Exclusion Criteria:
  • Pregnancy
  • Presence of an additional pulmonary disease beyond COPD
  • Inability to raise arms above 90 degrees as required for fluoroscopy

Exclusion

    Key Trial Info

    Start Date :

    January 7 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 30 2024

    Estimated Enrollment :

    17 Patients enrolled

    Trial Details

    Trial ID

    NCT04786171

    Start Date

    January 7 2021

    End Date

    May 30 2024

    Last Update

    June 21 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Vanderbilt University Medical Center

    Nashville, Tennessee, United States, 37232

    4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting | DecenTrialz